Event Details
Event Title Barry Kappel PhD Speaks on Making the Transition from Science to Business
Location Marsico 2004
Sponsor Training Initiative for Biological and Biomedical Sciences (TIBBS)
Date/Time 11/20/2019 1:30 PM - 3:30 PM
For more information, contact the event administrator: Patrick Brandt pdbrandt@email.unc.edu
Sorry, This event has expired
 

Barry Kappel, Ph.D., MBA, is the founder, President, Chief Executive Officer and Director of Sapience Therapeutics. As a biotechnology entrepreneur, executive and native New Yorker, Dr. Kappel is driven to help develop and foster the biotechnology community in New York. Sapience is the latest example of this effort.

Prior to founding Sapience, Dr. Kappel was a senior executive of ContraFect Corporation, a company which he played an integral part in founding in 2009. As the Senior Vice President of Business Development, he was involved in all aspects of the company, including financing activities, licensing of the company's key technologies, establishing scientific collaborations with academic and corporate partners, presenting to regulatory authorities and developing a corporate strategy. 

Prior to ContraFect, Dr. Kappel was a Senior Consultant at Easton Associates, LLC, a boutique life science consulting firm located in Manhattan. Easton Associates has since been acquired by Navigant Consulting.

Dr. Kappel holds a B.A. in Chemistry from Emory University, a Ph.D. in Immunology and Pharmacology from the Weill Cornell Graduate School of Medical Sciences and Memorial Sloan-Kettering Cancer Center, and an MBA from the S.C. Johnson Graduate School of Management at Cornell University. Dr. Kappel was also chosen as a Howard Hughes Pre-Doctoral Fellow and has published 17 articles in peer-reviewed scientific journals.

Barry Kappel, PhD, will speak on his career path, general career paths for PhDs in the business sector, and answer questions.  

UNC - Chapel Hill